Literature DB >> 12699963

15 million new cancer cases per year by 2020, says WHO.

Helen Frankish.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12699963     DOI： 10.1016/S0140-6736(03)13038-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.

Authors:  Tess E Cooper; Lauren C Heathcote; Brian Anderson; Marie-Claude Grégoire; Gustaf Ljungman; Christopher Eccleston
Journal:  Cochrane Database Syst Rev       Date:  2017-07-24

2.  Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.

Authors:  Subramaniam Mohana Devi; Vellingiri Balachandar; Meyyazhagan Arun; Shanmugam Suresh Kumar; Balasubramanian Balamurali Krishnan; Keshavarao Sasikala
Journal:  Dig Dis Sci       Date:  2012-10-02       Impact factor: 3.199

Review 3.  Buprenorphine for treating cancer pain.

Authors:  Mia Schmidt-Hansen; Nathan Bromham; Mark Taubert; Stephanie Arnold; Jennifer S Hilgart
Journal:  Cochrane Database Syst Rev       Date:  2015-03-31

Review 4.  Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.

Authors:  Islam Rady; Imtiaz A Siddiqui; Mohamad Rady; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2017-05-20       Impact factor: 8.679

5.  A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain.

Authors:  N A Hagen; B Lapointe; M Ong-Lam; B Dubuc; D Walde; B Gagnon; R Love; R Goel; P Hawley; A Ho Ngoc; P du Souich
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

Review 6.  Opioids for cancer-related pain in children and adolescents.

Authors:  Philip J Wiffen; Tess E Cooper; Anna-Karenia Anderson; Andrew L Gray; Marie-Claude Grégoire; Gustaf Ljungman; Boris Zernikow
Journal:  Cochrane Database Syst Rev       Date:  2017-07-19

7.  Subclinical kidney injury induced by repeated cisplatin administration results in progressive chronic kidney disease.

Authors:  Cierra N Sharp; Mark A Doll; Judit Megyesi; Gabrielle B Oropilla; Levi J Beverly; Leah J Siskind
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-31

Review 8.  Anticancer Properties of Graviola (Annona muricata): A Comprehensive Mechanistic Review.

Authors:  Islam Rady; Melissa B Bloch; Roxane-Cherille N Chamcheu; Sergette Banang Mbeumi; Md Rafi Anwar; Hadir Mohamed; Abiola S Babatunde; Jules-Roger Kuiate; Felicite K Noubissi; Khalid A El Sayed; G Kerr Whitfield; Jean Christopher Chamcheu
Journal:  Oxid Med Cell Longev       Date:  2018-07-30       Impact factor: 6.543

9.  Combining QSAR Modeling and Text-Mining Techniques to Link Chemical Structures and Carcinogenic Modes of Action.

Authors:  George Papamokos; Ilona Silins
Journal:  Front Pharmacol       Date:  2016-08-30       Impact factor: 5.810

10.  Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety.

Authors:  Mohammed S Abdel-Maksoud; Mohammed I El-Gamal; Mahmoud M Gamal El-Din; Chang Hyun Oh
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.